Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Invited Critique
Feb 2012

Statins for Everyone: Are We There Yet?Comment on “Effect of Perioperative Statins on Death, Myocardial Infarction, Atrial Fibrillation, and Length of Stay”

Author Affiliations

Author Affiliation: Department of Surgery, Stanford University, Stanford, California.

Arch Surg. 2012;147(2):189. doi:10.1001/archsurg.2011.1014

Chopra et al1 examined the effects of the lipid-lowering 3-hydroxy-3-methylglutaryl–coenzyme A reductase inhibitors (“statins”) on postoperative complications in patients who were naive to these medications. They performed a rigorous systematic review and meta-analysis of 15 studies with almost 2300 patients. The major findings were (1) 44% risk reduction for atrial fibrillation, with a number needed to treat of 6; (2) 47% risk reduction for myocardial infarction, with a number needed to treat of 23; and (3) a 32% reduction in hospital length of stay.

First Page Preview View Large
First page PDF preview
First page PDF preview